Cargando…

Legomedicine—A Versatile Chemo-Enzymatic Approach for the Preparation of Targeted Dual-Labeled Llama Antibody–Nanoparticle Conjugates

[Image: see text] Conjugation of llama single domain antibody fragments (Variable Heavy chain domains of Heavy chain antibodies, VHHs) to diagnostic or therapeutic nanoparticles, peptides, proteins, or drugs offers many opportunities for optimized targeted cancer treatment. Currently, mostly nonspec...

Descripción completa

Detalles Bibliográficos
Autores principales: van Lith, Sanne A. M., van Duijnhoven, Sander M. J., Navis, Anna C., Leenders, William P. J., Dolk, Edward, Wennink, Jos W. H., van Nostrum, Cornelus F., van Hest, Jan C. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330650/
https://www.ncbi.nlm.nih.gov/pubmed/28045502
http://dx.doi.org/10.1021/acs.bioconjchem.6b00638
_version_ 1782511261025566720
author van Lith, Sanne A. M.
van Duijnhoven, Sander M. J.
Navis, Anna C.
Leenders, William P. J.
Dolk, Edward
Wennink, Jos W. H.
van Nostrum, Cornelus F.
van Hest, Jan C. M.
author_facet van Lith, Sanne A. M.
van Duijnhoven, Sander M. J.
Navis, Anna C.
Leenders, William P. J.
Dolk, Edward
Wennink, Jos W. H.
van Nostrum, Cornelus F.
van Hest, Jan C. M.
author_sort van Lith, Sanne A. M.
collection PubMed
description [Image: see text] Conjugation of llama single domain antibody fragments (Variable Heavy chain domains of Heavy chain antibodies, VHHs) to diagnostic or therapeutic nanoparticles, peptides, proteins, or drugs offers many opportunities for optimized targeted cancer treatment. Currently, mostly nonspecific conjugation strategies or genetic fusions are used that may compromise VHH functionality. In this paper we present a versatile modular approach for bioorthogonal VHH modification and conjugation. First, sortase A mediated transPEGylation is used for introduction of a chemical click moiety. The resulting clickable VHHs are then used for conjugation to other groups employing the Cu(+)-independent strain-promoted alkyne–azide cycloadition (SPAAC) reaction. Using this approach, tail-to-tail bispecific VHHs and VHH-targeted nanoparticles are generated without affecting VHH functionality. Furthermore, this approach allows the bioconjugation of multiple moieties to VHHs for simple and convenient production of VHH-based theranostics.
format Online
Article
Text
id pubmed-5330650
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-53306502017-03-02 Legomedicine—A Versatile Chemo-Enzymatic Approach for the Preparation of Targeted Dual-Labeled Llama Antibody–Nanoparticle Conjugates van Lith, Sanne A. M. van Duijnhoven, Sander M. J. Navis, Anna C. Leenders, William P. J. Dolk, Edward Wennink, Jos W. H. van Nostrum, Cornelus F. van Hest, Jan C. M. Bioconjug Chem [Image: see text] Conjugation of llama single domain antibody fragments (Variable Heavy chain domains of Heavy chain antibodies, VHHs) to diagnostic or therapeutic nanoparticles, peptides, proteins, or drugs offers many opportunities for optimized targeted cancer treatment. Currently, mostly nonspecific conjugation strategies or genetic fusions are used that may compromise VHH functionality. In this paper we present a versatile modular approach for bioorthogonal VHH modification and conjugation. First, sortase A mediated transPEGylation is used for introduction of a chemical click moiety. The resulting clickable VHHs are then used for conjugation to other groups employing the Cu(+)-independent strain-promoted alkyne–azide cycloadition (SPAAC) reaction. Using this approach, tail-to-tail bispecific VHHs and VHH-targeted nanoparticles are generated without affecting VHH functionality. Furthermore, this approach allows the bioconjugation of multiple moieties to VHHs for simple and convenient production of VHH-based theranostics. American Chemical Society 2017-01-03 2017-02-15 /pmc/articles/PMC5330650/ /pubmed/28045502 http://dx.doi.org/10.1021/acs.bioconjchem.6b00638 Text en Copyright © 2017 American Chemical Society This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution License (http://pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html) , which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes.
spellingShingle van Lith, Sanne A. M.
van Duijnhoven, Sander M. J.
Navis, Anna C.
Leenders, William P. J.
Dolk, Edward
Wennink, Jos W. H.
van Nostrum, Cornelus F.
van Hest, Jan C. M.
Legomedicine—A Versatile Chemo-Enzymatic Approach for the Preparation of Targeted Dual-Labeled Llama Antibody–Nanoparticle Conjugates
title Legomedicine—A Versatile Chemo-Enzymatic Approach for the Preparation of Targeted Dual-Labeled Llama Antibody–Nanoparticle Conjugates
title_full Legomedicine—A Versatile Chemo-Enzymatic Approach for the Preparation of Targeted Dual-Labeled Llama Antibody–Nanoparticle Conjugates
title_fullStr Legomedicine—A Versatile Chemo-Enzymatic Approach for the Preparation of Targeted Dual-Labeled Llama Antibody–Nanoparticle Conjugates
title_full_unstemmed Legomedicine—A Versatile Chemo-Enzymatic Approach for the Preparation of Targeted Dual-Labeled Llama Antibody–Nanoparticle Conjugates
title_short Legomedicine—A Versatile Chemo-Enzymatic Approach for the Preparation of Targeted Dual-Labeled Llama Antibody–Nanoparticle Conjugates
title_sort legomedicine—a versatile chemo-enzymatic approach for the preparation of targeted dual-labeled llama antibody–nanoparticle conjugates
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330650/
https://www.ncbi.nlm.nih.gov/pubmed/28045502
http://dx.doi.org/10.1021/acs.bioconjchem.6b00638
work_keys_str_mv AT vanlithsanneam legomedicineaversatilechemoenzymaticapproachforthepreparationoftargetedduallabeledllamaantibodynanoparticleconjugates
AT vanduijnhovensandermj legomedicineaversatilechemoenzymaticapproachforthepreparationoftargetedduallabeledllamaantibodynanoparticleconjugates
AT navisannac legomedicineaversatilechemoenzymaticapproachforthepreparationoftargetedduallabeledllamaantibodynanoparticleconjugates
AT leenderswilliampj legomedicineaversatilechemoenzymaticapproachforthepreparationoftargetedduallabeledllamaantibodynanoparticleconjugates
AT dolkedward legomedicineaversatilechemoenzymaticapproachforthepreparationoftargetedduallabeledllamaantibodynanoparticleconjugates
AT wenninkjoswh legomedicineaversatilechemoenzymaticapproachforthepreparationoftargetedduallabeledllamaantibodynanoparticleconjugates
AT vannostrumcornelusf legomedicineaversatilechemoenzymaticapproachforthepreparationoftargetedduallabeledllamaantibodynanoparticleconjugates
AT vanhestjancm legomedicineaversatilechemoenzymaticapproachforthepreparationoftargetedduallabeledllamaantibodynanoparticleconjugates